glp-1 vomiting Struggling with therapy side effects? You're not alone. This Clinician Guide: Managing Common GLP-1 Receptor Agonist Side Effects provides practical tips on recognizing, preventing and managing gastrointestinal and nutritional side effects GLP-1 receptor agonists causing euglycemic

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist

Eli Lillys oral GLP-1 candidate orforglipron met all primary and secondary endpoints in a Phase 3 study of adults with type 2 diabetes, the

As I explore the potential of STDEI GLP-1, I'm intrigued by how this medication could transform diabetes management

Our pharmacist expert shares the differences and similarities between Wegovy and Ozempic.

Evidence shows some regain after stopping GLP-1s

Thus, oral administration of a peptide therapeutic represents a significant advance in medicine, but is challenged by gastrointestinal instability and ineffective uptake into the circulation